The differential effect of halothane and 1,2-dichlorohexafluorocyclobutane on in vitro muscle contractures of patients susceptible to malignant hyperthermia

Anesthesia and Analgesia

Volumn 94, Issue 4, 2002, Pages 1028-1033

  Kindler, Christoph H ^a   Girard, Thierry ^a   Gong, Diane ^a   Urwyler, Albert ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DICHLOROHEXAFLUOROCYCLOBUTANE; HALOTHANE; RYANODINE RECEPTOR;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALIGNANT HYPERTHERMIA; MUSCLE BIOPSY; MUSCLE CONTRACTILITY; PRIORITY JOURNAL;

EID: 0036209362     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200204000-00048     Document Type: Article

References (26)

1. Malignant hyperthermia
2. Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2
3. Ryanodine receptor mutations in malignant hyperthermia and central core disease
4. Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia
5. Standardization of the caffeine halothane muscle contracture test: North American Malignant Hyperthermia Group
6. A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility: The European Malignant Hyperpyrexia Group
7. Malignant hyperthermia
8. 3H]ryanodine binding to skeletal and cardiac ryanodine receptors
9. Halothane effects on human malignant hyperthermia skeletal muscle single calcium-release channels in planar lipid bilayers
10. 2+-regulatory membrane proteins by halothane
11. 2+ ions from human malignant hyperthermia-susceptible sarcoplasmic reticulum
12. Polyhalogenated and perfluorinated compounds that disobey the Meyer-Overton hypothesis
13. Diagnosis of susceptibility for malignant hyperthermia using in-vitro muscle contraction testing in Switzerland
14. Genotype-phenotype comparison of the Swiss malignant hyperthermia population
15. Potentiation of gamma-aminobutyric acid type A receptor-mediated chloride currents by novel halogenated compounds correlates with their abilities to induce general anesthesia
16. Enhancement of homomeric glycine receptor function by long-chain alcohols and anesthetics
17. Comparison of anesthetic and non-anesthetic effects on depolarization-evoked glutamate and GABA release from mouse cerebrocortical slices
18. Human neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes predict efficacy of halogenated compounds that disobey the Meyer-Overton rule
19. Volatile anesthetics increase intracellular calcium in cerebrocortical and hippocampal neurons
20. Differential effects of anesthetic and nonanesthetic cyclobutanes on neuronal voltage-gated sodium channels
21. The nonimmobilizer 1,2-dichlorohexafluorocyclobutane does not affect thermoregulation in the rat
22. + exchange in L6 muscle cells
23. Pharmacokinetics do not explain the absence of an anesthetic effect of perfluoropropane or perfluoropentane
24. Partial cloning and differential expression of ryanodine receptor/calcium-release channel genes in human tissues including the hippocampus and cerebellum
25. Genetics and pathogenesis of malignant hyperthermia
26. A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree